Dr. DR. FOLEFAC EDMUND

Clinical Trials

• Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
• Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
• S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Media Releases

Get to know Oncologist Dr. Edmund Folefac, who serves patients in Columbus, Ohio.

A seasoned oncologist specializing in genitourinary cancers, melanomas and lung cancers, Dr. Folefac works with patients at The Ohio State University Comprehensive Cancer Center – James (OSUCCC).

“At The James, we work to both treat patients’ diseases and prevent cancer through cutting-edge research and collaboration between skilled and diverse medical professionals. We provide individualized treatment plans to give our patients the best possible outcomes, because everyone’s individual cancer is different. I try to focus on how my patients are coping with their disease to ensure they have the support they need during this difficult time. The OSUCCC – James gives me the resources to pursue this goal of a cancer-free world” expressed Dr. Folefac.

A native of Nigeria, he completed his medical education and residency in general practice at the Obafemi Awolowo University. After relocating to the United States, he completed his internship and residency in internal medicine at the North Shore Medical Center Salem Hospital, and his fellowship in hematology/oncology at the Boston University Medical Center. He also earned his Master of Science degree at Boston University.

As a testament of his continued education, the doctor is board-certified in medical oncology, hematology, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

On a professional level, Dr. Edmund is a proud member of the American Medical Association, the International Society for the Study of Lung Cancer and other medical societies.

An enthusiastic researcher, he focuses primarily on smoking cessation in the context of preventing lung cancer. In addition, he focuses on screening, health care efficiency, cancer and aging, and personalized medicine. He has participated in numerous clinical trials, including one that focused on creating a brief, novel smoking cessation intervention. His research has been published in a number of journals, including the African Journal of Health Sciences.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, treat patients with radiation therapy, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management.

Recommended Articles

• The Promising Future of Gene Therapy and Lymphoma

  Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...

• Lymphoma: The Importance of a Support System & Communication

  Regardless of what’s being said, communication is something that many people struggle with in their personal relationships. Communication requires self-awareness, listening skills, and the ability to empathize and convey thoughts and feelings accurately. When people are diagnosed with chronic...

• Schools Join the Fight Against Lymphoma and Blood Cancers

  Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...

• Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause

  Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...

• Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma

  Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...